HIV-based vectors and angiogenesis following rabbit hindlimb ischemia

Journal of Surgical Research

Volumn 123, Issue 1, 2005, Pages 55-66

  Conklin, Lori D ^a   McAninch, Robin E ^b   Schulz, Daryl ^a   Kaluza, Grzegorz L ^a   Lemaire, Scott A ^a   Coselli, Joseph S ^a   Raizner, Albert E ^a   Sutton, Richard E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas ^*  (United States)

Author keywords

hindlimb ischemia; HIV based viral vector; therapeutic angiogenesis; vessel collateralization

Indexed keywords

ANGIOPOIETIN 2; ANTIBODY; GLYCOPROTEIN ANTIBODY; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; BLOOD SAMPLING; CAPILLARY DENSITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMORAL ARTERY; GENETIC TRANSFECTION; HINDLIMB; HUMAN IMMUNODEFICIENCY VIRUS VECTOR; ILIAC ARTERY; ISCHEMIA; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; SYSTOLIC BLOOD PRESSURE; THIGH; VENOUS BLOOD; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM;

ANGIOPOIETIN-2; ANIMALS; BASE SEQUENCE; GENE THERAPY; GENETIC VECTORS; HINDLIMB; HIV; ISCHEMIA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; SYSTOLE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL ENVELOPE PROTEINS;

EID: 11844293421     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.06.010     Document Type: Conference Paper

References (47)

1. R.N. Anderson Deaths Leading causes for 2000 Nat. Vit. Stats. Rep. 50 2002 16
2. R.E. Sutton, H.T. Wu, R. Rigg, E. Bohnlein, P.O. Brown Human immunodeficiency virus type I vectors efficiently transduce human hematopoietic stem cells J. Virol. 72 1998 5781
3. S. Takeshita, Y. Tsurumi, T. Couffinahl, T. Asahara, C. Bauters, J. Symes, N. Ferrara, J.M. Isner Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo Lab. Invest. 75 1996 487
4. T.T. Roe, T.C. Reynolds, G. Yu, P.O. Brown Integration of murine leukemia virus DNA depends on mitosis Embryo. J. 12 1993 2099
5. L. Naldini, U. Blomer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma, D. Trono In vivo delivery and stable transduction of nondividing cells by a lentiviral vector Science 272 1996 263
6. P. Corbeau, G. Kraus, F. Wong-Staal Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system Gene Ther. 5 1998 99
7. R.K. Akkina, R.M. Walton, M.L. Chen, Q.X. Li, V. Planelles, I.S. Chen High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G J. Virol. 70 1996 2581
8. Y. Tsurumi, M. Kearney, D. Chen, M. Silver, S. Takeshita, J. Yang, J.F. Symes, J.M. Isner Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene Circulation 96 1997 II-382
9. J. Reiser, G. Harmison, S. Kluepfel-Stahl, R.O. Brady, S. Karlsson, M. Schubert Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles Proc. Natl. Acad. Sci. USA 93 1996 15266
10. R.E. Sutton, H.T. Wu, R. Rigg, E. Bohnlein, P.O. Brown Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells J. Virol. 72 1998 5781
11. Y. Tsurumi, S. Takeshita, D. Chen, M. Kearney, S.T. Rossow, J. Passier, J.R. Horowitz, J.F. Symes, J.M. Isner Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion Circulation 94 1996 3281
12. E. van Belle, L. Maillard, F.O. Tio, J.M. Isner Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation Biochem. Biophys. Res. Commun. 235 1997 311
13. P.F. Lewis, M. Emerman Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus J. Virol. 68 1994 510
14. P. Lewis, M. Hensel, M. Emerman Human immunodeficiency virus infection of cells arrested in the cell EMBO. J. 11 1992 3053
15. P. Corbeau, G. Kraus, F. Wong-Staal Efficient gene transfer by a human immunodeficiency virus type I (HIV-I)-derived vector utilizing a stable HIV packaging cell line Proc. Natl. Acad. Sci. USA 93 1996 14070
16. E. Poeschia, P. Corbeau, F. Wong-Staal Development of HIV vectors for anti-HIV gene therapy Proc. Natl. Acad. Sci. USA 93 1996 11395
17. M.J. Goldman, P.S. Lee, J.S. Yang, J.M. Wilson Lentiviral vectors for gene therapy of cystic fibrosis Hum. Gene Ther. 8 1997 2261
18. U. Blomer, L. Naldini, T. Kafri, D. Trono, I.M. Verma, F.H. Gage Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector J. Virol. 71 1997 6641
19. L. Naldini, U. Blomer, F.H. Gage, D. Trono, I.M. Verma Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Proc. Natl. Acad. Sci. USA 93 1996 11382
20. H. Miyoshi, M. Takahashi, F.H. Gage, I.M. Verma Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector Proc. Natl. Acad. Sci. USA 94 1997 10319
21. J.M. Isner Therapeutic angiogenesis A new frontier for vascular therapy Vasc. Med. 1 1996 79
22. C. Bauters Growth factors as a potential new treatment for ischemic heart disease Clin. Cardiol. 20 1997 II-52
23. B.S. Lewis, M.Y. Flugelman, A. Weisz, I. Keren-Tal, W. Schaper Angiogenesis by gene therapy A new horizon for myocardial revascularization? Cardiovasc. Res. 35 1997 490
24. S. Takeshita, Y. Tsurumi, T. Couffinahl, T. Asahara, C. Bauters, J.F. Symes, N. Ferrara, J.M. Isner Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo Lab. Invest. 75 1996 487
25. S. Takeshita, L. Weir, D. Chen, L.P. Zheng, R. Riessen, C. Bauters, J.F. Symes, N. Ferrara, J.M. Isner Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys. Res. Commun. 227 1996 628
26. Y. Tsurumi, M. Kearney, D. Chen, M. Silver, S. Takeshita, J. Yang, J.F. Symes, J.M. Isner Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene Circulation 96 1997 II-382
27. Y. Tsurumi, M.S. Takeshita, D. Chen, M. Kearney, S.T. Rossow, J. Passeri, J.R. Horowitz, J.F. Symes, J.M. Isner Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion Circulation 94 1996 3281
28. E. Van Belle, L. Maillard, F.O. Tio, J.M. Isner Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation Biochem. Biophys. Res. Commun. 235 1997 311
29. I. Baumgartner, A. Pieczek, O. Manor, R. Blair, M. Kearney, K. Walsh, J.M. Isner Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 1998 1114
30. J.M. Isner Myocardial gene therapy Nature 415 2002 234
31. J.M. Isner, I. Baumgartner, G. Rauh, R. Schainfeld, R. Blair, O. Manor, S. Razvi, J.F. Symes Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor preliminary clinical results J. Vasc. Surg. 28 1998 964 discussion 73
32. J.M. Isner, A. Pieczek, R. Schainfeld, R. Blair, L. Haley, T. Asahara, K. Rosenfield, S. Razvi, K. Walsh, J.F. Symes Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Lancet 348 1996 370
33. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, M. Maysky, A.B. Ashare, K. Lathi, J.M. Isner Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800
34. J.F. Symes, D.W. Losordo, P.R. Vale, K.G. Lathi, D.D. Esakof, M. Mayskiy, J.M. Isner Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease Ann. Thorac. Surg. 68 1999 830 discussion 836
35. P.R. Vale, D.W. Losordo, C.E. Milliken, M.C. McDonald, L.M. Gravelin, C.M. Curry, D.D. Esakof, M. Maysky, J.F. Symes, J.M. Isner Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia Circulation 103 2001 2138
36. N.W. Gale, G. Thurston, S. Davis, S.J. Wiegand, J. Holash, J.S. Rudge, G.D. Yancopoulos, S.F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, C. Witte, M.H. Witte, D. Jackson, C. Suri, P.A. Campochiaro Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation Cold Spring Harb. Symp. Quant. Biol. 67 2002 267
37. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242
38. U. Fiedler, T. Krissl, S. Koidl, C. Weiss, T. Koblizek, U. Deutsch, G. Martiny-Baron, D. Marme, H.G. Augustin Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats J. Biol. Chem. 278 2003 1721
39. S. Tsigkos, M. Koutsilieris, A. Papapetropoulos Angiopoietins in angiogenesis and beyond Expert. Opin. Investig. Drugs 12 2003 933
40. I.B. Lobov, P.C. Brooks, R.A. Lang Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo Proc. Natl. Acad. Sci. USA 99 2002 11205
41. R.P. Visconti, C.D. Richardson, T.N. Sato Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF) Proc. Natl. Acad. Sci. USA 99 2002 8219
42. N.W. Gale, G. Thurston, S.F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, C. Witte, M.H. Witte, D. Jackson, C. Suri, P.A. Campochiaro, S.J. Wiegand, G.D. Yancopoulos Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1 Dev. Cell. 3 2002 411
43. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, S.M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, J.K. Rose An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 106 2001 539
44. S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J.L. Villeval, C.C. Fraser, M. Cavazzana-Calvo, A. Fischer A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N. Engl. J. Med. 348 2003 255
45. S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L.E. Leiva, M. Wissler, C. Prinz, T.H. Rabbitts, F. Le Deist, A. Fischer, M. Cavazzana-Calvo, E. McIntyre, I. Radford, J.L. Villeval, C.C. Fraser LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415
46. B. Burgess-Beusse, C. Farrell, M. Gaszner, M. Litt, V. Mutskov, F. Recillas-Targa, M. Simpson, A. West, G. Felsenfeld The insulation of genes from external enhancers and silencing chromatin Proc. Natl. Acad. Sci. USA 99 Suppl 4 2002 16433
47. F. Bushman Targeting retroviral integration? Mol. Ther. 6 2002 570